Biosimilars in Oncology, IBD, GI, Rheumatology & Dermatology

Description :

  • Safety and efficacy of biosimilars in oncology
  • Acceptance of Biosimilars in Oncology
  • Biosimilar Therapies for Cancer
  • Changing attitudes for biosimilars in gastroenterology
  • Development of biosimilars and potential cost savings
  • Clinical evidence supporting similarity of biosimilars to originator biologics
  • Biosimilars: patient’s view and HCPs’ knowledge